Significant progress has been made in drugs for allergic diseases, and sublingual immunotherapy becomes the first choice
Which of the various new formulations such as the new crown vaccine nasal spray will succeed?
Text | Little Pharmacist of Shanghai Beach
Recently, CanSino Bio (688185.
Milestone progress in allergic diseases, the world's first Artemisia pollen sublingual immunotherapy drug was launched
Eur Arch Otorhinolaryngol: The relationship between nasal cavity patency and changes in orofacial muscle function in patients with asthma and rhinitis
The FDA accepts the nasal drug methyl sulfonate dehydroquinolamine (DHE) INP104
Innovative medicine for acute migraines! FDA accepts nasal drug methyl sulfonate dehydroquine amine
Russia has developed a new crown vaccine for nasal drips
New drugs for depression! Johnson and Johnson Spravato nasal spray approved in the European Union